DHPA President Dr. Michael Weinstein testified before the U.S. House Energy & Commerce Health Subcommittee during a hearing entitled “Examining Barriers to Expanding Innovative Value-Based Care in Medicare.” Dr. Weinstein testified that expanding Alternative Payment Models (APMs) to independent practices will enable health care to move to a more cost-efficient setting. Dr. Weinstein urged Congress […]
Protecting Patient Access to Integrated GI Care in the Independent Setting
In an age when quality of care, cost-effectiveness and transparency are more important than ever, data demonstrates that high-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting.
DHPA joined a coalition of 240 patient and provider groups signing onto a letter to U.S. Senate and U.S. House leaders asking them to urge the Centers for Medicare & Medicaid Services (CMS) to reconsider a proposal to allow Medicare Advantage plans to implement step therapy to manage Part B drugs. CMS originally announced the […]
DHPA joined the Patient-Centered Evaluation and Management Services Coalition in sending a letter to Centers for Medicare and Medicaid Services (CMS) and Congressional leadership supporting CMS’s proposed simplification of documentation requirements and opposing implementation of proposed payment changes in the Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2019. In the letters, the Coalition […]
The Digestive Health Physicians Association has submitted a comment letter in response to the Centers for Medicare & Medicaid Services’ Request for Information on the Physician Self-Referral (Stark) law. DHPA is committed to ensuring that independent GI practices across the country can participate in alternative payment models (APMs) and other novel financial arrangements that deliver […]
DHPA has submitted comments to the U.S. Health and Human Services Request for Information entitled “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.” In the comment letter, DHPA focuses on several of the key initiatives highlighted in the RFI: DHPA supports site neutrality for physician-administered drugs across the hospital and independent physician practice settings […]